News
COPAN is focused on the industry standard quality of its innovative products and remains actively committed to protecting its intellectual property rights globally, including the patent infringement and unfair competition lawsuit that COPAN filed in U.S. federal district court last year.
Read MoreMaine’s highest court, the Maine Supreme Judicial Court, affirmed a summary judgment entered in favor of Copan Italia S.p.A. and against Puritan Medical Products Company, LLC on Puritan’s state law claim for bad faith assertion of patent infringement.
Read MoreCOPAN Announces the Worldwide Launch of CYCLONE AUTO-PREP™ with Smart Incubators and AI for Automatic Determination of Bacterial Growth During the Upcoming International Association for Food Protection (IAFP) Annual Meeting
Read MoreCOPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc. announced today that they have filed a lawsuit against Puritan Medical Products Co., LLC and Puritan Diagnostics LLC, in the United States District Court for the District of Maine for infringement of U.S. Patent No. 8,114,027, U.S. Patent No. 8,317,728, U.S. Patent No. 8,979,784, U.S. Patent No. 9,011,358, and U.S. Patent No. 9,173,779.
Read MoreCOPAN announces its North American launch
of the new Collaborative Robot, its latest addition to Full Laboratory Automation.
Recent multicenter study by Dr. Carey-Ann D. Burnham et al adds another application to the growing number of uses and endorsements for COPAN’s widely popular ESwab™. ESwab™ comprises of 1ml of liquid Amies and a flocked swab that completely elutes the sample into the preservation medium.
Read MoreCopan Italia and Shinji Matsuura proudly announce the formation of a joint venture for the strategic promotion and distribution of Copan’s Liquid Based Microbiology range in Japan.
Read MoreLivermore, Calif. – October 20, 2017 – Not-for-profit Sutter Health and COPAN Diagnostics, Inc. (Murrieta, Calif.) today announced the deployment of full automation technology at the Sutter Health Shared Laboratory in Livermore. WASPLab® will improve patient care by speeding up the diagnosis process, leading to decreases in both cost and length of hospital stays.
Read MoreThe new WASPLab® at University Health Network/Sinai Health System’s Department of Microbiology in Toronto, Ontario marks the 60th worldwide placement of the innovative instrument.
Read MoreAfter a successful launch at the American Society for Microbiology (ASM) Microbe 2017, COPAN is showcasing PhenoMATRIX™ to a wider audience at the American Association for Clinical Chemistry (AACC) annual meeting at the San Diego Convention Center from August 1 through August 3.
Read More